Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Charles L. Densmore"'
Publikováno v:
American Journal of Respiratory Medicine
Delivery of therapeutic genes to the lungs is an attractive strategy to correct a variety of pulmonary dysfunctions such as cystic fibrosis, alpha-1 antitrypsin deficiency, pulmonary hypertension, asthma, and lung cancer. Different delivery routes su
Autor:
Berma M. Kinsey, Frank M. Orson, Philip R. Wyde, Yan Wu, Innocent N. Mbawuike, Tina Nguyen, Charles L. Densmore
Publikováno v:
The Journal of Gene Medicine. 8:488-497
Background Conventional vaccine development for newly emerging pandemic influenza virus strains would likely take too long to prevent devastating global morbidity and mortality. If DNA vaccines can be distributed and delivered efficiently, genetic im
Publikováno v:
Current Gene Therapy. 5:181-194
The lung represents an important target for gene therapy: for correction of genetic abnormalities such as cystic fibrosis, for lung cancer therapy, and for vaccination. Genes in the form of expression plasmids can be delivered both by the intravenous
Autor:
Charles L. Densmore
Publikováno v:
Expert Opinion on Biological Therapy. 3:1083-1092
The delivery of genes by inhalation holds promise for the treatment of a wide range of pulmonary and non-pulmonary disorders and offers numerous advantages over more invasive modes of delivery. Subsequent to the cloning of the cystic fibrosis gene, t
Autor:
Brian E. Gilbert, Luz Roberts, Charles L. Densmore, J.C. Waldrep, Vernon Knight, Nadezhda V. Koshkina, Ajay Gautam, Sara Melton
Publikováno v:
Gene Therapy. 9:353-357
Growth inhibition of established tumor metastases in the lungs poses a difficult challenge for most clinical settings in spite of extensive multi-modality approaches. Aerosol delivery of drugs and genes holds promise for the treatment of disseminated
Autor:
Laura L. Worth, Vernon Knight, Charles L. Densmore, Ajay Gautam, Yuen Kai Fung, Eugenie S. Kleinerman, J. Clifford Waldrep, Bo Xu, Anne T'ang, Shu Fang Jia
Publikováno v:
Cancer Gene Therapy. 8:619-627
Lung metastases are a frequent complication of osteosarcoma and a treatment that would reduce the severity of this complication would be of great benefit to patients. We have used a formulation consisting of polyethyleneimine (PEI) and a p53 gene adm
Publikováno v:
Molecular Therapy. 3(4):551-556
Gene therapy targeted at the respiratory epithelium holds therapeutic potential for diseases such as cystic fibrosis and α-1 anti-trypsin deficiency. A variety of approaches such as intranasal or intratracheal instillation and aerosol delivery have
Publikováno v:
Molecular Therapy. 2(4):318-323
Mutations in the p53 tumor suppressor gene and the pathways mediated by the p53 protein are common in many human cancers. Replacement of functional p53 by gene therapy is a potential way of combating these cancers and the associated drug resistance a
Publikováno v:
Molecular Therapy. 2:63-70
Aerosol gene delivery to the pulmonary system has vast potential for many diseases, including cystic fibrosis and lung cancer. We recently reported that polyethyleneimine (PEI), a cationic polymer, holds promise as a gene delivery vector for transfec
Autor:
Balbir Bhogal, Bo Xu, Frank M. Orson, Pascal Hua, Berma M. Kinsey, J. Clifford Waldrep, Vernon Knight, Charles L. Densmore
Publikováno v:
Molecular Therapy. 1(2):180-188
Aerosol delivery of plasmid DNA to the lungs offers the possibility of direct application of gene preparations to pulmonary surfaces as a means of treating a variety of genetic pulmonary disorders. However, the process of jet nebulization rapidly deg